首页 > 抗体蛋白 > 抗体
APC anti-human CD8a Antibody
产品名称:
APC anti-human CD8a Antibody
产品类别:
抗体
产品编号:
301014
产品应用:
301014
[价格]
规格 价格 库存
100tests ¥ 1008 1

产品详情

Product Details

Verified Reactivity
Human, Cynomolgus, Rhesus
Reported Reactivity
Chimpanzee, Baboon, Pigtailed Macaque, Sooty Mangabey
Antibody Type
Monoclonal
Host Species
Mouse
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA)
Preparation
The antibody was purified by affinity chromatography, and conjugated with APC under optimal conditions.
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is 5 ?l per million cells in 100 ?l staining volume or 5 ?l per 100 ?l of whole blood.

Excitation Laser
Red Laser (633 nm)
Application Notes

The RPA-T8 antibody does not block the binding of HIT8a antibody to CD8a. Additional reported applications of this antibody (for the relevant formats) include: immunohistochemical staining of paraformaldehyde-fixed frozen sections3 and costimulation of T cell responses4. This clone was tested in-house and does not work on formalin fixed paraffin-embedded (FFPE) tissue. The Ultra-LEAF? purified antibody (Endotoxin <0.1 EU/?g, Azide-Free, 0.2 ?m filtered) is recommended for functional assays (Cat. Nos. 301073 & 301074).

Application References

(PubMed link indicates BioLegend citation)
  1. Knapp W, et al. Eds. 1989. Leucocyte Typing IV. Oxford University Press. New York.
  2. Schlossman S, et al. Eds. 1995. Leucocyte Typing V. Oxford University Press. New York.
  3. Mack CL, et al. 2004. Pediatr. Res. 56:79. (IHC)
  4. Magidovich E, et al. 2007. P. Natl. Acad. Sci. USA 104:13022.
  5. Thakarl D, et al. 2008.J. immunol. 180:7431. PubMed
  6. Kmieciak M, et al. 2009. J. Transl. Med. 7:89. (FC) PubMed
  7. Thakral D, et al. 2008. J. Immunol. 180:7431. (FC) PubMed
  8. Yoshino N, et al. 2000. Exp. Anim. (Tokyo) 49:97. (FC)
  9. Rout N, et al. 2010. PLoS One 5:e9787. (FC)
  10. Stoeckius M, et al. 2017. Nat. Methods. 14:865. (PG)
Product Citations
  1. Frazzette N, et al. 2020. NPJ Precis Oncol. 4:13. PubMed
  2. Xiao C, et al. 2022. iScience. 25:103934. PubMed
  3. Wang Z, et al. 2021. Cell Mol Immunol. 18:2188. PubMed
  4. Vignard V, et al. 2020. Cancer Immunol Res. 0.510416667. PubMed
  5. Eriksson E, et al. 2016. Gene Ther. 10.1038/gt.2016.80. PubMed
  6. Hu W, et al. 2021. Vaccines (Basel). 9:. PubMed
  7. Vanuytsel K, et al. 2022. Nat Commun. 13:1103. PubMed
  8. Zhang J, et al. 2022. Nature. 609:369. PubMed
  9. Cai J, et al. 2021. eLife. 10:00. PubMed
  10. Kacherovsky N, et al. 2019. Nat Biomed Eng. 0.66875. PubMed
  11. Sperk M, et al. 2021. iScience. 24:102111. PubMed
  12. Nakasone H, et al. 2021. Commun Biol. 4:1177. PubMed
  13. Vikkurthi R, et al. 2022. Nat Microbiol. 7:974. PubMed
  14. Li N, et al. 2020. Oncoimmunology. 9:1824643. PubMed
  15. Trinklein ND, et al. 2019. MAbs. 11:639. PubMed
  16. Zheng Q, et al. 2017. Mol Oncol. 10.1002/1878-0261.12056. PubMed
  17. Hwang B, et al. 2021. Nat Methods. 18:903. PubMed
  18. Sam J, et al. 2020. Front Oncol. 10:575737. PubMed
  19. Halim TYF et al. 2018. Immunity. 48(6):1195-1207 . PubMed
  20. G?rtner K, et al. 2019. J Extracell Vesicles. 8:1573051. PubMed
  21. ?yszkiewicz M, et al. 2020. Nat Commun. 11:1031. PubMed
  22. Akusj?rvi SS, et al. 2022. iScience. 25:103607. PubMed
  23. Corgnac S, et al. 2022. J Immunother Cancer. 10:. PubMed
  24. Zhai Y, et al. 2018. Autophagy. 1.714583333. PubMed
  25. Frazzette N, et al. 2020. NPJ Precis Oncol. 4:13. PubMed
  26. Svensson Akusj?rvi S, et al. 2022. Commun Biol. 5:357. PubMed
  27. Chang ZL, et al. 2020. Nature Protocols. 15(4):1507-1524.. PubMed
  28. Cimen Bozkus C, et al. 2021. STAR Protoc. 2:100758. PubMed
RRID
AB_314132 (BioLegend Cat. No. 301014) AB_2562054 (BioLegend Cat. No. 301049)

Antigen Details

Structure
Ig superfamily, homodimer or heterodimer with CD8β, 32-34 kD
Distribution

Majority of thymocytes, T cell subset, NK cells

Function
MHC class I co-receptor, thymic differentiation, T cell activation
Ligand/Receptor
MHC Class I molecules
Cell Type
Dendritic cells, NK cells, T cells, Thymocytes, Tregs
Biology Area
Immunology
Molecular Family
CD Molecules
Antigen References

1. Barclay N, et al. 1993. The Leucocyte Antigen FactsBook. Academic Press Inc. San Diego.

Gene ID
925 View all products for this Gene ID
UniProt
View information about CD8a on UniProt.org

联系我们

TEL:021-34661275  点击拨打热线